General
Showing 1089–1104 of 1342 results
-
Article: Real-life outcome of optimally treated patients with malignant glioma
€3.03 Add to cart -
Article: Real-life value of follow-up FDG-PET/CT (FU-FDG-PET/CT) in patients with locoregionally advanced squamous cell carcinoma of the head and neck (LA-HNSCC) treated with chemoradiation (CRT) or (chemo)radiation ([C]RT) preceded by induction chemotherapy (IC) (sequential treatment [ST]).
€3.03 Add to cart -
Article: Real-world evidence for implementation of new drugs
€3.03 Add to cart -
Article: Real-world evidence with durvalumab after chemoradiotherapy in patients with unresectable NSCLC
€3.03 Add to cart -
Article: Real-world treatment practices for EGFR-mutant NSCLC patients
€3.03 Add to cart -
Article: Rebuttal to ‘The COMPARZ study presented at ESMO 2012: how pliable is non-inferiority?’
€3.03 Add to cart -
Article: Rebuttal to “The role of direct oral anticoagulants in the management of cancer-associated thrombosis’
€3.03 Add to cart -
Article: Recent advances in small-cell lung cancer treatment
€3.03 Add to cart -
Article: Recent updates on perioperative immunotherapy for patients with resectable NSCLC
€3.03 Add to cart -
Article: Recurrent and metastatic non-nasopharyngeal head and neck cancer: state of the art of systemic treatment
€3.03 Add to cart -
Article: Refining Stereotactic Body Radiotherapy for Oligometastatic Gynaecologic Tumours: Key Insights from 2024
€3.03 Add to cart -
Article: Reflex testing for mutations in patients with early-stage non-small cell lung cancer: practical implications from ADAURA
€3.03 Add to cart -
Article: Refractory pyrexia caused by BRAF and MEK inhibitors: Colchicine as salvage
€3.03 Add to cart -
Article: Relationship between volume and outcome in lung cancer
€3.03 Add to cart -
Article: Renal cell carcinoma
€3.03 Add to cart -
Article: Renal cell carcinoma with TFE3 rearrangement at Xp11.2
€3.03 Add to cart
